| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 02/23/2011 | EP2285787A2 3-substituted propanamine compounds |
| 02/23/2011 | EP2285775A1 Therapeutic lactams |
| 02/23/2011 | EP2285376A1 6-aminonicotinamide derivatives as potent and selective histone deacetylase inhibitors |
| 02/23/2011 | EP2155731B1 1, 3-dihydroimidazole- 2 -thione derivatives as inhibitors of dopamine-beta-hydroxylase |
| 02/23/2011 | EP2027104B1 Arylsulfonylchromans as 5-ht6 inhibitors |
| 02/23/2011 | EP1697347B1 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 02/23/2011 | EP1682520B1 Amide derivatives |
| 02/23/2011 | EP1409461B1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides |
| 02/23/2011 | EP1227805B2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 02/23/2011 | EP1000023B1 Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 02/23/2011 | CN1942466B Caspase inhibitors and uses thereof |
| 02/23/2011 | CN101981011A Pyridyl derivatives as CFTR modulators |
| 02/23/2011 | CN101981006A Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 02/23/2011 | CN101979382A Aminoindazole derivatives and use thereof as kinase inhibitors |
| 02/23/2011 | CN101250163B Process for producing epoxytriazole compound and intermediate therefor |
| 02/23/2011 | CN101039907B Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 02/22/2011 | US7893268 Epithiolone analogues |
| 02/22/2011 | US7893262 Process for the preparation of 2H-chromenes |
| 02/22/2011 | US7893090 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/22/2011 | US7893084 Viral polymerase inhibitors |
| 02/22/2011 | US7893074 inhibition of focal adhesion kinase or/and IGF-1 Receptor; for example: 2-[2-(2,5-Dimethoxy-phenylamino)-5-nitro-pyrimidin-4-ylamino]-N-methyl-benzenesulfonamide |
| 02/22/2011 | US7893073 Heterocyclic derivatives |
| 02/22/2011 | US7893071 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic |
| 02/22/2011 | US7893068 Physiologically active substances |
| 02/22/2011 | US7893063 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer |
| 02/22/2011 | US7893052 CGRP receptor antagonists |
| 02/22/2011 | US7893048 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 02/22/2011 | CA2553879C Viral polymerase inhibitors |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
| 02/22/2011 | CA2319198C Substituted oxoazaheterocyclyl factor xa inhibitors |
| 02/17/2011 | WO2011019864A2 Methods for mobile zinc measurement |
| 02/17/2011 | WO2011019799A2 Copper catalyzed cycloaddition of organic azides and 1-haloalkynes |
| 02/17/2011 | WO2011019681A1 Selective sphingosine-1-phosphate receptor antagonists |
| 02/17/2011 | WO2011019634A2 Aryl substituted sulfonamide compounds and their use as anticancer agents |
| 02/17/2011 | WO2010138828A3 Potassium channel modulators |
| 02/17/2011 | WO2010122980A8 NOVEL THYROID HORMONE β RECEPTOR AGONIST |
| 02/17/2011 | US20110039894 Substituted enaminothiocarbonyl compounds |
| 02/17/2011 | US20110039865 Phenyl(oxy/thio)alkanol Derivatives |
| 02/17/2011 | US20110039853 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 02/17/2011 | US20110039833 1-benzoyl substituted diazepine derivatives as selective histamine h3 receptor agonists |
| 02/17/2011 | US20110039829 Pyrazole-carboxamide derivatives as p2y12 antagonists |
| 02/17/2011 | US20110039828 Tetrahydroquinoline derivatives and a process for preparing the same |
| 02/17/2011 | US20110039821 Fused Phenyl Amido Heterocyclic Compounds |
| 02/17/2011 | CA2771083A1 Selective sphingosine-1-phosphate receptor antagonists |
| 02/16/2011 | EP2284164A2 Substituted tetracycline compounds |
| 02/16/2011 | EP2284159A1 5-hydroxypyrimidine-4-carboxamide compound |
| 02/16/2011 | EP2284157A1 Quinolines useful in treating cardiovascular disease |
| 02/16/2011 | EP2283015A2 4-oxo-1,4-dihydroquinoline m1 receptor positive allosteric modulators |
| 02/16/2011 | EP2282999A1 Amino-quinoxaline and amino-quinoline compounds for use as adenosine a2a receptor antagonists |
| 02/16/2011 | EP2046762B1 Triazolyl phenyl benzenesulfonamides |
| 02/16/2011 | EP1771422B1 Quinazolinone derivatives as parp inhibitors |
| 02/16/2011 | EP1664035B1 2,4 di(hetero)-arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors |
| 02/16/2011 | EP1309568B1 [(quinazolin-4-yl)piperazin-4-yl]thiocarboxamide compounds as inhibitors of the phosphorylation of a PDGF receptor |
| 02/16/2011 | CN1972926B Indole derivatives as histamine receptor antagonists |
| 02/16/2011 | CN101977904A Aminopiperidinyl derivatives and uses thereof |
| 02/16/2011 | CN101977900A 5-fluoro pyrimidine derivatives |
| 02/16/2011 | CN101977655A Indazole derivatives |
| 02/16/2011 | CN101973987A Epothilone analogue, preparation method as well as medicine composition and application thereof |
| 02/16/2011 | CN101973935A Preparation method and application of N-substituted-3,5-dibenzal piperidine-4-one |
| 02/16/2011 | CN101048465B Polymeric luminescent material composition and polymeric light-emitting device |
| 02/16/2011 | CN101012203B 1,2,4-triazol derivatives, method for preparing the same |
| 02/15/2011 | US7888510 1,4-disubstituted piperidine compounds like N-(9-Ethyl-9H-carbazol-3-yl)-2-[4-(2-hydroxymethyl-6-methyl-phenylamino)-piperidine-yl]acetamide; chloroacetyl chloride is reacted with respective compounds in the presence of dichloromethane and triethylamine or diisopropylethylamine |
| 02/15/2011 | US7888487 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 02/15/2011 | US7888366 2,4-diaminoquinazolines for spinal muscular atrophy |
| 02/15/2011 | US7888363 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-amino/thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 02/15/2011 | US7888360 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/15/2011 | CA2615271C Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 02/15/2011 | CA2558272C Pyridone derivative |
| 02/15/2011 | CA2529452C Serum cholesterol lowering agent or preventive or therapeutic agent for atherosclerosis |
| 02/15/2011 | CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/15/2011 | CA2470067C Imidazoquinoline derivatives |
| 02/15/2011 | CA2449234C Quinazoline derivatives which promote the release of parathyroid hormone |
| 02/15/2011 | CA2446864C Inhibitors of src and other protein kinases |
| 02/15/2011 | CA2380272C Stable near-infrared (nir) marker dyes based on benzopyrylium-polymethines |
| 02/10/2011 | WO2011017533A1 Crystalline salts of methyl 2- ( (r) - ( 3-chloro phenyl) ( (r) -l- ( (s) -2- (methylamino) -3- ( (r) -tetrahydro-2h-pyran-3-yl) propylcarbamoyl ) |
| 02/10/2011 | WO2011016528A1 Aminopyrazole derivative |
| 02/10/2011 | WO2011016472A1 Pyridine and pyrimidine derivatives having ttk-inhibiting activity |
| 02/10/2011 | WO2011016468A1 Benzyl piperidine compound |
| 02/10/2011 | WO2011016234A1 Picolinamide derivatives as ttx-s blockers |
| 02/10/2011 | WO2011015646A2 Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 02/10/2011 | US20110034511 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists |
| 02/10/2011 | US20110034509 Beta-2-Adrenoreceptor Agonists |
| 02/10/2011 | US20110034463 Type iii secretion inhibitors, analogs and uses thereof |
| 02/10/2011 | US20110034450 Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereof |
| 02/10/2011 | US20110034435 Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers |
| 02/10/2011 | US20110034433 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use |
| 02/10/2011 | US20110034378 Pharmaceutical Combinations Comprising Specified Age Breaker and Further Drugs, I.A. Antihypertensive Drugs, Antidiabetic Drugs Etc. |
| 02/10/2011 | CA2770195A1 Aminopyrazole derivative |
| 02/10/2011 | CA2769977A1 Benzylpiperidine compound |
| 02/09/2011 | EP2281824A1 Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 02/09/2011 | EP2281818A1 Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2011 | EP2281817A1 Substituted carbinol compound having cyclic linker |
| 02/09/2011 | EP2281815A1 4-(Acetylamino)-3-[(4-chlorophenyl)thio]-2-methyl-1H-indole-1-acetic acid ethyl ester intermediate compound |
| 02/09/2011 | EP2281563A1 2,4-Pyrimidinediamine compounds and their uses |
| 02/09/2011 | EP2281560A1 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucomatous optic neuropathy |
| 02/09/2011 | EP2280945A1 Trisubstituted pyrazoles as acetylcholine receptor modulators |
| 02/09/2011 | EP2280940A1 Novel n-(2-amino-phenyl)-acrylamides |
| 02/09/2011 | EP2280699A1 Novel estrogen receptor ligands |
| 02/09/2011 | EP2280601A2 Amino acid inhibitors of cytochrome p450 |
| 02/09/2011 | EP2033637B1 Therapeutic or prophylactic agent for leukemia |